Screening for muscle loss and thinking changes after cancer
Part of Brain & nervous system, Cancer, Mental health clinical trials.
This study looks at how common muscle weakness (sarcopenia) and thinking or memory changes (often called “chemobrain”) are in people after cancer treatment. It may help teams understand what support could be most helpful after chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old
- Your original cancer was in one of these places: breast, lung, melanoma, testicle, bladder, kidney, ovary, colon, pancreas, or blood system (hemopathy)
- You have had a post-cancer assessment visit (“post-cancer assessment day”)
- You received chemotherapy (chemical treatment)
- You are willing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
This study looks at whether doctors can spot “low muscle” (sarcopenia) in everyday clinic care for people with ovarian or endometrial cancer who are planning to start chemotherapy. It may help your care team identify muscle loss early and potentially support better treatment planning.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
This study looks at muscle health and aging in adults who had childhood cancer. Researchers want to see how muscle mass and strength change over time and what factors (like past treatments) might affect this.
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
This study looks at changes in thinking, behavior, and brain structure that can happen when people with cancer lose weight and appetite (called cachexia). Researchers will use questionnaires and brain scans to understand these changes, which may help improve care for people with cancer.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.